Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis

Background: Recurrent respiratory papillomatosis (RRP) is a rare disorder characterized by the generation of papillomas of the aerodigestive tract, usually associated with human papilloma virus (HPV) subtypes 6, 11. INO-3106 is a DNA plasmid-based immunotherapy targeting E6 and E7 proteins of HPV6,...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Charu, Cohen, Roger B., Morrow, Matthew P., Kraynyak, Kimberly A., Sylvester, Albert J., Cheung, Jocelyn, Dickerson, Kelsie, Schulten, Veronique, Knoblock, Dawson, Gillespie, Elisabeth, Bauml, Joshua M., Yan, Jian, Diehl, Malissa, Boyer, Jean, Dallas, Michael, Kim, J. Joseph, Weiner, David B., Skolnik, Jeffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158680/
https://www.ncbi.nlm.nih.gov/pubmed/32013270
http://dx.doi.org/10.3390/vaccines8010056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158680/
https://www.ncbi.nlm.nih.gov/pubmed/32013270
http://dx.doi.org/10.3390/vaccines8010056

Ejemplares similares